Prague, Czechia

Michal Voslar

This inventor holds 1 USPTO granted patent and 1 published patent application and 3 EPO patents. Top assignee: Zentiva K.s.. Active years: 2012.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Michal Voslar. Retrieved from https://idiyas.com/inventor/michal-voslar

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

 

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2012

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovator Michal Voslar and His Contributions to Zolmitriptan Preparation

Introduction

Michal Voslar, an accomplished inventor based in Praha, Czech Republic, has made notable contributions to the field of pharmaceutical chemistry, particularly with his innovative work on zolmitriptan. As an inventor, he holds a patent that showcases his expertise and dedication to improving medicinal formulations.

Latest Patents

Michal Voslar is recognized for his patent titled "Method for the Preparation of Zolmitriptan." The patented technique focuses on reducing the diazonium salt to (5)-4-(4-hydrazinobenzyl)-1,3-oxazolidin-2-one in a concentrated mixture, utilizing an alkali metal disulphite, specifically sodium disulphite. His innovative approach also covers the creation of a zolmitriptan toluene solvate, characterized by a toluene content of 9 to 14% by weight, verified through gas chromatography. Additionally, the solvate is distinguished by significant Raman bands, providing insight into its crystal lattice structure with incorporated toluene.

Career Highlights

Michal Voslar is currently associated with Zentiva, a renowned pharmaceutical company where he continues to pursue advancements in drug formulation and development. His dedication to research and innovation has played a crucial role in enhancing the efficiency and effectiveness of pharmaceuticals, particularly for migraine treatment through zolmitriptan.

Collaborations

Throughout his career, Voslar has collaborated with notable colleagues, including Monika Zatopkova and Ludek Ridvan. Their joint efforts in the lab have contributed to the refinement of methodologies and the exploration of new avenues in pharmaceutical research, enhancing the impact of their collective work.

Conclusion

In conclusion, Michal Voslar exemplifies the spirit of innovation that drives progress in the pharmaceutical industry. With his patent on the preparation of zolmitriptan, he has contributed valuable knowledge to the field, showcasing the importance of research and collaboration in creating effective therapies. His work not only reflects his personal achievements but also paves the way for future developments in the realm of medicinal chemistry.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…